Mangalam Drugs And Organics Limited — Others, 08-08-2025: Copy of Newspaper Publication

Mangalam Drugs and Organics Limited has published its financial results for the quarter ended June 30, 2025. The Board of Directors approved these results in its meeting held on August 7, 2025. For the quarter, total income from operations was Rs 57.35 Cr. The company reported a net loss of Rs 12.93 Cr (standalone) and Rs 13.00 Cr (consolidated) after tax. This update provides key insights into the company's recent financial performance, crucial for investors tracking its operational health and profitability trends.